Sagent, Qilu partner to commercialise complex injectable products in US
Pharmaceutical Business Review
JULY 8, 2025
By combining Qilu’s proven development and manufacturing capabilities with Sagent’s strong commercial platform, deep market insight, and agile market approach, we look forward to advancing patient care and contributing to a more reliable, accessible pharmaceutical supply chain.”
Let's personalize your content